Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.

Fnu Nutan, Alex G Ortega-Loayza

Journal: The journal of investigative dermatology. Symposium proceedings 2018;18(2):S64-S68

PMID: 28941497

Free Full Text on Elsevier Science View on PubMed

Abstract

Systemic lupus erythematosus is a chronic inflammatory condition which affects predominantly women in their 30s. It has several clinical manifestations, including skin lesions that can be classified as acute cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, and chronic cutaneous lupus erythematosus. A multifaceted approach to treating cutaneous lupus is advocated.

Address: Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA. Electronic address: [email protected].; Department of Dermatology, Virginia Commonwealth University, Richmond, Virginia, USA.

DOI: 10.1016/j.jisp.2017.02.001

Link outs

Free resources

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S1087...

Other Literature Sources:

https://scite.ai/reports/28941497

Subscription / membership required

Other Literature Sources:

https://facultyopinions.com/pubmed/28941497

MeSH Terms: Adrenal Cortex Hormones, Antibodies, Monoclonal, Antimalarials, Calcineurin Inhibitors, Dapsone, Humans, Immunologic Factors, Lenalidomide, Lupus Erythematosus, Cutaneous, Methotrexate, Mycophenolic Acid, Retinoids, Thalidomide